Seo Jung-jin "Celltrion Holdings to Pursue Nasdaq Listing in the US"

Seong-Jin Seo Holds 98.5% Stake in Celltrion Holdings

Seo Jung-jin, chairman of the Celltrion Group, announced plans to list the holding company Celltrion Holdings on the US Nasdaq stock exchange.

According to industry sources on the 15th, Chairman Seo revealed this plan while attending as a speaker at the Korea Economic Association Future Leaders Camp held in Gangneung, Gangwon Province the previous day. Seo is the largest shareholder, holding 98.5% of Celltrion Holdings' shares.

Chairman Seo reportedly stated, "I have instructed the relevant departments to list Celltrion Holdings on Nasdaq as early as the end of this year, or at the latest, early next year."

At the JP Morgan Healthcare Conference held in San Francisco, USA, from the 8th to the 11th (US time), he announced plans following the merger of the Celltrion Group to list Celltrion Holdings by the end of the year at the earliest, and to use the funds raised as seed money to establish a global healthcare fund worth 100 trillion won.

He previously revealed plans to directly invest about 5 trillion won from the funds raised through the listing and to attract capital from other investors to raise a total of 100 trillion won. Although Chairman Seo has announced plans to list Celltrion Holdings several times, this is the first time he has expressed a clear intention to list on Nasdaq.